Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 17;195(49):E1722.
doi: 10.1503/cmaj.230859.

Anterior uveitis and diffuse scleritis after pamidronate infusion

Jim S Xie  1 , Alexander J Kaplan  2
Affiliations

Anterior uveitis and diffuse scleritis after pamidronate infusion

Jim S Xie et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1:
Figure 1:
A) Pamidronate-induced anterior uveitis and diffuse scleritis in a 58-year-old woman. Proptosis, hypopyon (blue arrow) and scleral injection and edema (green arrow) began within 48 hours of pamidronate infusion. B) A computed tomography scan of the orbits showed right-sided proptosis and circumferential scleral thickening and hypervascularity with adjacent edema (green arrow), consistent with diffuse scleritis.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. French DD, Margo CE. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 2008;28:889–93. - PubMed
    1. Chartrand NA, Lau CK, Parsons MT, et al. . Ocular side effects of bisphosphonates: a review of literature. J Ocul Pharmacol Ther 2023;39:3–16. - PubMed
    1. Abdalla Elsayed MEA, Kozak I. Pharmacologically induced uveitis. Surv Ophthalmol 2021;66:781–801. - PubMed

MeSH terms